Japan Approves Leqembi, All Eyes Now On Extended Pricing Discussions

Concizumab, Tenapanor, Others Get Nods

 
• By Lisa Takagi
Japan is going to discuss leqembi's pricing with wide range of effects including cutting down nursing costs.
Japan to discuss Leqembi's pricing from a broad perspective including its potential reduction of care costs • Source: Shutterstock

More from Japan

More from Asia